Impact of Covid-19 pandemic on injection-based practice : report from an Italian multicenter and multidisciplinary survey
Background: There are no papers exploring the impact of COVID-19 pandemic on the injection-based practice in patients affected by different rheumatic diseases, including osteoarthritis. The aim was to investigate the impact of COVID-19 pandemic on injection-based practice trough the Italian country.
Study design: A survey-based retrospective cross-sectional study.
Methods: An Italian-language questionnaire was developed by a group of senior researchers and distributed by e-mail to some Rheumatology, Orthopedic and Rehabilitation Units from different geographic areas of Italy. The survey included information about the number of injections performed during COVID-19 pandemic (stratified by injected agents and injected joint), in comparison to the pre-pandemic period, and the possible reasons behind an eventual reduction. Responses were collected and descriptive analysis calculated.
Results: Eleven centers of the National Health Service completed the survey. The activities of the injections services significantly decreased across the country with a percentage of reduction of 60% compared to the pre-pandemic period. A significant reduction of both intra-articular and peri-articular injections was registered. Among intra-articular. treatments, the most affected ones were the hyaluronic acid injections, when compared to corticosteroids. A significant decrease of the total amount of peri-articular injections was observed. The strict government restrictions and the fear of patients to become infected represented the most limiting factors.
Conclusions: The reported decrease of the injection-based practice in our country during the COVID-19 pandemic highlights the detrimental effects of the COVID-19 pandemic on the management of chronic musculoskeletal diseases with possible negative consequences in terms of disability and quality of life.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:34 |
---|---|
Enthalten in: |
Annali di igiene : medicina preventiva e di comunita - 34(2022), 5 vom: 15. Sept., Seite 501-514 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Tenti, S [VerfasserIn] |
---|
Links: |
---|
Themen: |
COVID-19 |
---|
Anmerkungen: |
Date Completed 25.07.2022 Date Revised 29.07.2022 published: Print Citation Status MEDLINE |
---|
doi: |
10.7416/ai.2022.510 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM343817497 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM343817497 | ||
003 | DE-627 | ||
005 | 20231226021332.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.7416/ai.2022.510 |2 doi | |
028 | 5 | 2 | |a pubmed24n1146.xml |
035 | |a (DE-627)NLM343817497 | ||
035 | |a (NLM)35861721 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Tenti, S |e verfasserin |4 aut | |
245 | 1 | 0 | |a Impact of Covid-19 pandemic on injection-based practice |b report from an Italian multicenter and multidisciplinary survey |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 25.07.2022 | ||
500 | |a Date Revised 29.07.2022 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Background: There are no papers exploring the impact of COVID-19 pandemic on the injection-based practice in patients affected by different rheumatic diseases, including osteoarthritis. The aim was to investigate the impact of COVID-19 pandemic on injection-based practice trough the Italian country | ||
520 | |a Study design: A survey-based retrospective cross-sectional study | ||
520 | |a Methods: An Italian-language questionnaire was developed by a group of senior researchers and distributed by e-mail to some Rheumatology, Orthopedic and Rehabilitation Units from different geographic areas of Italy. The survey included information about the number of injections performed during COVID-19 pandemic (stratified by injected agents and injected joint), in comparison to the pre-pandemic period, and the possible reasons behind an eventual reduction. Responses were collected and descriptive analysis calculated | ||
520 | |a Results: Eleven centers of the National Health Service completed the survey. The activities of the injections services significantly decreased across the country with a percentage of reduction of 60% compared to the pre-pandemic period. A significant reduction of both intra-articular and peri-articular injections was registered. Among intra-articular. treatments, the most affected ones were the hyaluronic acid injections, when compared to corticosteroids. A significant decrease of the total amount of peri-articular injections was observed. The strict government restrictions and the fear of patients to become infected represented the most limiting factors | ||
520 | |a Conclusions: The reported decrease of the injection-based practice in our country during the COVID-19 pandemic highlights the detrimental effects of the COVID-19 pandemic on the management of chronic musculoskeletal diseases with possible negative consequences in terms of disability and quality of life | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Multicenter Study | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a SARS-CoV-2 | |
650 | 4 | |a corticosteroids | |
650 | 4 | |a hyaluronic acid | |
650 | 4 | |a intra-articular therapy | |
650 | 4 | |a musculoskeletal diseases | |
700 | 1 | |a Mondanelli, N |e verfasserin |4 aut | |
700 | 1 | |a Bernetti, A |e verfasserin |4 aut | |
700 | 1 | |a Mangone, M |e verfasserin |4 aut | |
700 | 1 | |a Agostini, F |e verfasserin |4 aut | |
700 | 1 | |a Capassoni, M |e verfasserin |4 aut | |
700 | 1 | |a Cheleschi, S |e verfasserin |4 aut | |
700 | 1 | |a De Chiara, R |e verfasserin |4 aut | |
700 | 1 | |a Farì, G |e verfasserin |4 aut | |
700 | 1 | |a Frizziero, A |e verfasserin |4 aut | |
700 | 1 | |a Giannotti, S |e verfasserin |4 aut | |
700 | 1 | |a Guiducci, S |e verfasserin |4 aut | |
700 | 1 | |a Masiero, S |e verfasserin |4 aut | |
700 | 1 | |a Megna, M |e verfasserin |4 aut | |
700 | 1 | |a Messina, C |e verfasserin |4 aut | |
700 | 1 | |a Moretti, L |e verfasserin |4 aut | |
700 | 1 | |a Tognolo, L |e verfasserin |4 aut | |
700 | 1 | |a Gigliucci, G |e verfasserin |4 aut | |
700 | 1 | |a Santilli, V |e verfasserin |4 aut | |
700 | 1 | |a Migliore, A |e verfasserin |4 aut | |
700 | 1 | |a Fioravanti, A |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Annali di igiene : medicina preventiva e di comunita |d 1989 |g 34(2022), 5 vom: 15. Sept., Seite 501-514 |w (DE-627)NLM012634999 |x 1120-9135 |7 nnns |
773 | 1 | 8 | |g volume:34 |g year:2022 |g number:5 |g day:15 |g month:09 |g pages:501-514 |
856 | 4 | 0 | |u http://dx.doi.org/10.7416/ai.2022.510 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 34 |j 2022 |e 5 |b 15 |c 09 |h 501-514 |